✦ LIBER ✦

Hepatitis A and hepatitis B vaccinations: immunogenicity of combined vaccine and of simultaneously or separately applied single vaccines

✍ Scribed by Peter A. Czeschinski; Norbert Binding; Ute Witting

Book ID: 117433644
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 152 KB
Volume: 18
Category: Article
ISSN: 0264-410X
DOI: 10.1016/s0264-410x(99)00354-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunogenicity and reactogenicity of a c

Immunogenicity and reactogenicity of a combined hepatitis A-hepatitis B vaccine in adolescents

✍ Sandra C. Thompson; Maureen Norris 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 498 KB

Immunogenicity of combined hepatitis A a

Immunogenicity of combined hepatitis A and B vaccine in elderly persons

✍ Bernd Wolters; Ulrich Junge; Stefan Dziuba; Michael Roggendorf 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 166 KB

Combined Hepatitis A and B Vaccines

✍ David L. Murdoch, Karen Goa, David P. Figgitt 📂 Article 📅 2003 🏛 Springer International Publishing AG 🌐 English ⚖ 339 KB

Comparative immunogenicity of two vaccin

Comparative immunogenicity of two vaccination schedules of a combined hepatitis A and B vaccine in healthy volunteers

✍ A. De Schryver; K. Verstrepen; L. Vandersmissen; N. Vandermeeren; I. Vernaillen; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Combined Vaccination against Hepatitis A

Combined Vaccination against Hepatitis A, Hepatitis B, and Typhoid Fever: Safety, Reactogenicity, and Immunogenicity

✍ Stephan Proell; Hubert Maiwald; Hans-Dieter Nothdurft; Roland Saenger; Jens Voll 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB

Safety and immunogenicity of a recombina

Safety and immunogenicity of a recombinant hepatitis B vaccine

✍ E. Dandolos; A. Roumeliotou-Karayannis; S. C. Richardson; Prof. G. Papaevangelou 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 340 KB

A hepatitis B vaccine produced in yeast by recombinant DNA technology was evaluated using 5-micrograms and 10-micrograms doses in a randomized trial lasting 7 months in 110 male armed forces recruits aged 17-19 years. Results were compared to those of an identical trial of a plasma-derived vaccine.